Research and Reporting Methods19 October 2010
    Author, Article, and Disclosure Information



    No regulations govern placebo composition. The composition of placebos can influence trial outcomes and merits reporting.


    To assess how often investigators specify the composition of placebos in randomized, placebo-controlled trials.

    Data Sources:

    4 English-language general and internal medicine journals with high impact factors.

    Study Selection:

    3 reviewers screened titles and abstracts of the journals to identify randomized, placebo-controlled trials published from January 2008 to December 2009.

    Data Extraction:

    Reviewers independently abstracted data from the introduction and methods sections of identified articles, recording treatment type (pill, injection, or other) and whether placebo composition was stated. Discrepancies were resolved by consensus.

    Data Synthesis:

    Most studies did not disclose the composition of the study placebo. Disclosure was less common for pills than for injections and other treatments (8.2% vs. 26.7%; P = 0.002).


    Journals with high impact factors may not be representative.


    Placebos were seldom described in randomized, controlled trials of pills or capsules. Because the nature of the placebo can influence trial outcomes, placebo formulation should be disclosed in reports of placebo-controlled trials.

    Primary Funding Source:

    University of California Foundation Fund 3929—Medical Reasoning.


    • 1. Schulz KFAltman DGMoher DCONSORT GroupCONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med2010;152:726-32. [PMID: 20335313] LinkGoogle Scholar
    • 2. Kaptchuk TJStason WBDavis RBLegedza ARSchnyer RNKerr CEet alSham device v inert pill: randomised controlled trial of two placebo treatments. BMJ2006;332:391-7. [PMID: 16452103] CrossrefMedlineGoogle Scholar
    • 3. Moseley JBO'Malley KPetersen NJMenke TJBrody BAKuykendall DHet alA controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med2002;347:81-8. [PMID: 12110735] CrossrefMedlineGoogle Scholar
    • 4. Gragoudas ESAdamis APCunningham ETFeinsod MGuyer DRVEGF Inhibition Study in Ocular Neovascularization Clinical Trial GroupPegaptanib for neovascular age-related macular degeneration. N Engl J Med2004;351:2805-16. [PMID: 15625332] CrossrefMedlineGoogle Scholar
    • 5. McCann ILHolmes DSInfluence of aerobic exercise on depression. J Pers Soc Psychol1984;46:1142-7. [PMID: 6737208] CrossrefMedlineGoogle Scholar
    • 6. Streitberger KKleinhenz JIntroducing a placebo needle into acupuncture research. Lancet1998;352:364-5. [PMID: 9717924] CrossrefMedlineGoogle Scholar
    • 7. Golomb BAParadox of placebo effect [Letter]. Nature1995;375:530. [PMID: 7791863] CrossrefMedlineGoogle Scholar
    • 8. Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiological Statistics for Public Health. Version 2.3 ed. Vol. 2010; 2009. Google Scholar
    • 9. Moher DHopewell SSchulz KFMontori VGøtzsche PCDevereaux PJet alCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c869. [PMID: 20332511] CrossrefMedlineGoogle Scholar
    • 10. Acheson JHutchinson ECControlled trial of clofibrate in cerebral vascular disease. Atherosclerosis1972;15:177-83. [PMID: 4579955] CrossrefMedlineGoogle Scholar
    • 11. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians. Br Med J1971;4:775-84. [PMID: 4943606] CrossrefMedlineGoogle Scholar
    • 12. Cullinen KOlive oil in the treatment of hypercholesterolemia. Med Health R I2006;89:113. [PMID: 16596937] MedlineGoogle Scholar
    • 13. Covas MIBioactive effects of olive oil phenolic compounds in humans: reduction of heart disease factors and oxidative damage. Inflammopharmacology2008;16:216-8. [PMID: 18815741] CrossrefMedlineGoogle Scholar
    • 14. Fito MCladellas Mde la Torre RAlcántara MPujadas-Bastardes MMarrugat Jet almembers of the SOLOS InvestigatorsAntioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis2005;181:149-58. [PMID: 15939067] CrossrefMedlineGoogle Scholar
    • 15. Loprinzi CLEllison NMSchaid DJKrook JEAthmann LMDose AMet alControlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst1990;82:1127-32. [PMID: 2193166] CrossrefMedlineGoogle Scholar
    • 16. Osterlund PRuotsalainen TPeuhkuri KKorpela ROllus AIkonen Met alLactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol2004;2:696-703. [PMID: 15290663] CrossrefMedlineGoogle Scholar
    • 17. Wedlake LThomas KMcGough CAndreyev HJSmall bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational study. Eur J Cancer2008;44:2212-7. [PMID: 18760593] CrossrefMedlineGoogle Scholar
    • 18. Golomb BADoctoring the evidence: the case against lying to patients about placebos. Am J Bioeth2009;9:34-6. [PMID: 20013497] CrossrefMedlineGoogle Scholar
    • 19. Golomb BWhen are medication side effects due to the nocebo phenomenon? [Letter]. JAMA2002;287:2502-3. [PMID: 12020325] MedlineGoogle Scholar
    • 20. Eccles RMechanisms of the placebo effect of sweet cough syrups. Respir Physiol Neurobiol2006;152:340-8. [PMID: 16326149] CrossrefMedlineGoogle Scholar
    • 21. Paul IMBeiler JMcMonagle AShaffer MLDuda LBerlin CMEffect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med2007;161:1140-6. [PMID: 18056558] CrossrefMedlineGoogle Scholar